Browse studies

Find your next paid study

1 recruiting study matching your filters

An Open-Label, Dose Escalation, Phase I/II Clinical Trial of ET140203 T Cells in Pediatric Subjects With Relapsed/Refractory Hepatoblastoma (HB), Hepatocellular Neoplasm-Not Otherwise Specified (HCN-NOS), or Hepatocellular Carcinoma (HCC)

Open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety/tolerability and determine the recommended Phase II Dose (RP2D) of ET…

HepatoblastomaHepatocellular Carcinoma (HCC)Liver Neoplasms+3 more

Eureka Therapeutics Inc.NCT04634357